From Lab to Life: GLP-1 Prevents Heart Attacks |
Science Daily reports that a large international review study found that “GLP-1 [glucagon-like peptide-1] weight-loss drugs [e.g. Ozempic] significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term.”*
“A massive review of over 90,000 patients found that popular GLP-1 weight-loss drugs like semaglutide significantly lowered the risk of heart attacks, strokes, heart failure, and even premature death over several years of treatment.”
The story of how GLP-1 drugs for weight loss were discovered is fascinating, and is highly instructive about how science often takes a long winding road toward a surprising and powerful result.
GLP-1 drugs began with the study of gut hormones in the 1970s and took an unexpected detour through the venom of the Gila monster lizard. The discovery and........